Displaying 1121 - 1140 of 1557
Maintaining Competition, FTC Allows Fresenius $3.5 Billion Deal to Buy Rival Dialysis Provider Renal Care Group
FTC Proposes Study of Competitive Impacts of Authorized Generic Drugs
Hospitals Plan for Collective Bargaining of Physicians Fees Likely Would Violate Federal Laws, FTC Staff Says
Health Care Alliance of Laredo, L.C., In the Matter of
Preserving Competition, FTC Requires Divestiture Before Allowing Allergans Acquisition of Inamed
Teva Pharmaceutical Industries Ltd. and IVAX Corporation, In the Matter of
The consent order allowed Teva to acquire IVAX Corporation, provided the companies sell the rights and assets needed to manufacture and market 15 generic pharmaceutical products. Among the drugs sold were several forms of generic amoxicillin and amoxicillin clavulanate potassium that are widely used in the United States.
FTC Staff Files Comments on New Jerseys Proposed Advertising Guideline 4; Commission Finalizes Teva/Ivax Consent Order
Texas Doctors' IPA Agrees to Settle Price Fixing Charges
Davita Inc. Submits Petition for Approval of Proposed Divestiture; FTC Submits Budget Request and Performance Plans to Congress
Announced Action for January 27, 2006
Preserving Competition, FTC Requires Divestitures Before Allowing Tevas $7.4 Billion Acquisition of IVAX
Commission Finds That North Texas Specialty Physicians Illegally Fixed Prices
In re Tamoxifen Citrate Antitrust Litigation
Announced Action for November 18, 2005
FTC Sues to Stop Anticompetitive Agreement in U.S. Drug Industry
Administrative Law Judge Orders Evanston Northwestern Healthcare Corporation to Sell Highland Park Hospital
FTC Accepts Settlement to Remedy DaVita's Acquisition of Rival Outpatient Dialysis Clinic Provider Gambro
Health Care: An Interview with Commissioner Thomas B. Leary
Displaying 1121 - 1140 of 1557